Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
Saved in:
| Title: | Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. |
|---|---|
| Authors: | Kandula, Mahesh1 kmahesh@cellixbio.com, Sunil Kumar, KB1 kbsunil@cellixbio.com, Palanichamy, Sivanesan1 sivanesanp@cellixbio.com, Rampal, Ashok1 rampala@cellixbio.com |
| Source: | International Immunopharmacology. Nov2016, Vol. 40, p443-451. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 15675769 |
|---|---|
| DOI: | 10.1016/j.intimp.2016.09.013 |
